| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/17/2002 | EP1222683A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 07/17/2002 | EP1222459A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 07/17/2002 | EP1222302A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 07/17/2002 | EP1222300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 07/17/2002 | EP1222289A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 07/17/2002 | EP1222286A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 07/17/2002 | EP1222284A2 22196, a novel human aminopeptidase |
| 07/17/2002 | EP1222279A2 Growth factor polypeptides and nucleic acids encoding same |
| 07/17/2002 | EP1222277A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 07/17/2002 | EP1222276A2 Polynucleotides and polypeptides encoded thereby |
| 07/17/2002 | EP1222274A2 Mage-a12 antigenic peptides and uses thereof |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222266A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 07/17/2002 | EP1222259A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222252A1 New lymphocytes, a process for preparing the same and their use in therapeutics |
| 07/17/2002 | EP1222226A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 07/17/2002 | EP1222212A1 Il13 mutants |
| 07/17/2002 | EP1222211A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 07/17/2002 | EP1222200A1 Vaccine |
| 07/17/2002 | EP1222193A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 07/17/2002 | EP1222191A2 Benzodiazepin derivatives, the production and use thereof |
| 07/17/2002 | EP1222188A1 Novel imidazopyridine carbonitrile compounds |
| 07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP1222175A1 4,5-disubstituted-2-aminopyrimidines |
| 07/17/2002 | EP1222174A1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase |
| 07/17/2002 | EP1222170A1 Novel nicotinonitrile compounds |
| 07/17/2002 | EP1222169A1 Novel trisubstituted pyridine compounds |
| 07/17/2002 | EP1222162A1 Novel ltb 4? antagonist, method for the production thereof and its use as a medicament |
| 07/17/2002 | EP1221977A2 Tumor detection by imaging and therapy of tumors |
| 07/17/2002 | EP1221976A1 Low dose ifn-gamma for treatment of disease |
| 07/17/2002 | EP1221974A2 Magnetic targeted carrier |
| 07/17/2002 | EP1221973A1 CD40 antagonist for treating psoriasis |
| 07/17/2002 | EP1221971A2 Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 07/17/2002 | EP1221969A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 07/17/2002 | EP1221966A1 Method for reducing the risk of cancer |
| 07/17/2002 | EP1221961A1 Induction of a strong immune response to a self-tumor associated antigen |
| 07/17/2002 | EP1221959A2 Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221940A2 Liposome formulation of 6,9-bis- (2-aminoethyl)-amino]benzo g]isoquinoline-5,10-dione dimaleate |
| 07/17/2002 | EP1221939A1 Ortho ester lipids |
| 07/17/2002 | EP1221908A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/17/2002 | EP1221847A1 Methods of enhancing chemotherapy |
| 07/17/2002 | EP1066293B1 New porphyrins and their use |
| 07/17/2002 | EP1042327A4 A process for the reduction of oxiranyl epothilones to olefinic epothilones |
| 07/17/2002 | EP0925278B1 Cytostatic hydroxamic acid derivatives |
| 07/17/2002 | EP0901492B1 Taxane derivatives, the preparation thereof and formulations containing them |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0888298B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 07/17/2002 | EP0866709A4 1,2,4-benzotriazine oxides formulations |
| 07/17/2002 | EP0749452B1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
| 07/17/2002 | EP0694035B1 Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents |
| 07/17/2002 | EP0686156B1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 07/17/2002 | EP0511306B1 Tumor killing effects of enterotoxins and related compounds |
| 07/17/2002 | CN1359420A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 07/17/2002 | CN1359392A Coupled compound of erythropoietin with glycol |
| 07/17/2002 | CN1359391A 重组腺病毒 Recombinant adenovirus |
| 07/17/2002 | CN1359384A Taxane derivatives and processes for the preparation thereof |
| 07/17/2002 | CN1359381A Thiazole-derivaties |
| 07/17/2002 | CN1359380A Diaminothiazoles and their use for inhibiting protein kinases |
| 07/17/2002 | CN1359376A Carboxylic acid derivatives compriosing aryl-substituted nitrogen heterocycles, their production and their use as endothel in receptor antagonists |
| 07/17/2002 | CN1359370A Esters of L-carnitine or alkanoyl L-carnitines |
| 07/17/2002 | CN1359298A Novel indications of mannan-bindie lectin (MBL) in the treatment of immanocompromised individuals |
| 07/17/2002 | CN1359297A Method for preventing tumoral growth |
| 07/17/2002 | CN1358859A Antisense oligonucleotide structure and use of cell propagation receptor IGFIK |
| 07/17/2002 | CN1358857A Antisense oligonucleotide structure and use using fade-inhibition factor API4 as target |
| 07/17/2002 | CN1358734A 5 alpha, 8 alpha-epidioxy-24-dimethycholestane-6-alkene-three beta-alcohol and its heterosides and ester preparation process and use |
| 07/17/2002 | CN1358732A Antisense oligonucleitde structure and use using serine/threonine kinase AIM-1 gene as target |
| 07/17/2002 | CN1358731A Antisense oligonucleotide structure and use using serine/threonine kinase P[K] gene as target |
| 07/17/2002 | CN1358730A Oligose capable of being used as medicine and its surfated products and preparation process thereof, and medicinal composition having same |
| 07/17/2002 | CN1358720A Three-site substituted beta-carboline novel compound having anti-HIV and anti-cancer activity |
| 07/17/2002 | CN1358541A Application of hepatocyte forming agent self-secretion circulation in diagnosis and treatment of liver cancer |
| 07/17/2002 | CN1358539A Ointment for treating ulcer and hyperplastic skin and preparation process |
| 07/17/2002 | CN1358536A Medicine for treating lymphatic tuberculosis and lymphoma |
| 07/17/2002 | CN1358535A Tumor-eliminaitng ointment and preparation process |
| 07/17/2002 | CN1358531A Medicine for treating cancer |
| 07/17/2002 | CN1358523A Toxic substance removing ointment |
| 07/17/2002 | CN1087631C Radiolabeled peptides for diagnosis and therapy |
| 07/17/2002 | CN1087624C Chinese-medicina decoction for treating lung diseases |
| 07/17/2002 | CN1087612C Anti-cancer compound preparation |
| 07/17/2002 | CN1087609C Chalcones and esters thereof with antiproliferative activity ini uterus, ovary and breast tumours |
| 07/17/2002 | CA2367825A1 Antithrombin iii for disorders caused by angiogenesis |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420572 Flavanoid derivatives and phenolic derivatives with halogenation |
| 07/16/2002 | US6420546 Oligoribonucleotide and ribozyme analogs with terminal 3′—3′ and/or 5′—5′ linkages |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420411 Compounds and methods for use thereof in the treatment of cancer or viral infections |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420387 Antitumor |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420382 Tyrosine kinase inhibitors |
| 07/16/2002 | US6420379 Alkynyl-substituted camptothecins and process for their preparation |
| 07/16/2002 | US6420371 Angiogenesis inhibitor |
| 07/16/2002 | US6420370 Pyrimidine derivatives and method of making and using derivatives |
| 07/16/2002 | US6420348 Pectic polysaccharides purified from Angelica gigas nakai and purification method and use as immunostimulating agent thereof |
| 07/16/2002 | US6420345 Methods and reagents for inhibiting angiogenesis |